| 3.37 -0.05 (-1.46%) | 07-13 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.39 | 1-year : | 5.12 |
| Resists | First : | 3.75 | Second : | 4.39 |
| Pivot price | 3.34  |
|||
| Supports | First : | 2.99 | Second : | 2.52 |
| MAs | MA(5) : | 3.29 |
MA(20) : | 3.3 |
| MA(100) : | 2.89 |
MA(250) : | 3.67 |
|
| MACD | MACD : | 0 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 46.3 |
D(3) : | 37.3 |
| RSI | RSI(14): 54.4 |
|||
| 52-week | High : | 8.39 | Low : | 1.84 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ACH ] has closed below upper band by 46.4%. Bollinger Bands are 24.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.53 - 3.55 | 3.55 - 3.57 |
| Low: | 3.32 - 3.34 | 3.34 - 3.36 |
| Close: | 3.34 - 3.37 | 3.37 - 3.4 |
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
Mon, 13 Jul 2026
Accendra Health (ACH) Has Home-Care Scale, but the Debt Stack Drives the Risk - AlphaStreet
Sun, 12 Jul 2026
Price to sales forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Sun, 12 Jul 2026
Accendra Health (ACH) is One of The 15 Best NYSE Penny Stocks According to Hedge Funds - Yahoo Finance
Tue, 23 Jun 2026
Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations - Business Wire
Thu, 18 Jun 2026
ACH News | ACCENDRA HEALTH INC (NYSE:ACH) - ChartMill
Mon, 11 May 2026
Accendra Health (ACH) Shares Jump After First-Quarter Earnings Beat - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 77 (M) |
| Shares Float | 56 (M) |
| Held by Insiders | 7.7 (%) |
| Held by Institutions | 85.6 (%) |
| Shares Short | 5,860 (K) |
| Shares Short P.Month | 6,070 (K) |
| EPS | -1.38 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -6.08 |
| Profit Margin | -39.9 % |
| Operating Margin | -1.1 % |
| Return on Assets (ttm) | 1.5 % |
| Return on Equity (ttm) | -198.4 % |
| Qtrly Rev. Growth | -6.9 % |
| Gross Profit (p.s.) | 16.32 |
| Sales Per Share | 35.51 |
| EBITDA (p.s.) | 4.22 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -117 (M) |
| Levered Free Cash Flow | 650 (M) |
| PE Ratio | -2.46 |
| PEG Ratio | 0.6 |
| Price to Book value | -0.56 |
| Price to Sales | 0.09 |
| Price to Cash Flow | -2.21 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|